Literature DB >> 24268009

Cardiac manifestations of systemic lupus erythematosus.

Jonathan J Miner1, Alfred H J Kim.   

Abstract

The heart is one of the most frequently affected organs in SLE. Any part of the heart can be affected, including the pericardium, myocardium, coronary arteries, valves, and the conduction system. In addition to pericarditis and myocarditis, a high incidence of CAD has become increasingly recognized as a cause of mortality, especially in older adult patients and those with long-standing SLE. Many unanswered questions remain in terms of understanding the pathogenesis of cardiac manifestations of SLE. It is not currently possible to predict the patients who are at greatest risk for the various types of cardiac involvement. However, with the rapid advancement of basic science and translational research approaches, it is now becoming easier to identify specific mutations associated with SLE. A better understanding of these genetic factors may eventually allow clinicians to categorize and predict the patients who are at risk for specific cardiac manifestations of SLE.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Congenital heart block; Coronary artery disease; Libman-Sacks; Myocarditis; Neonatal lupus; Pericarditis; Systemic lupus erythematosus

Mesh:

Year:  2014        PMID: 24268009     DOI: 10.1016/j.rdc.2013.10.003

Source DB:  PubMed          Journal:  Rheum Dis Clin North Am        ISSN: 0889-857X            Impact factor:   2.670


  30 in total

Review 1.  Cardiohepatic syndrome.

Authors:  Gerhard Poelzl; Johann Auer
Journal:  Curr Heart Fail Rep       Date:  2015-02

2.  Dyspnoea in lupus.

Authors:  Jeremy Fleri Soler; Andrew Borg; Cecilia Mercieca
Journal:  BMJ Case Rep       Date:  2017-11-08

3.  Lupus myocarditis receiving the rituximab therapy-a monocentric retrospective study.

Authors:  Chrong-Reen Wang; Yi-Shan Tsai; Wei-Ting Li
Journal:  Clin Rheumatol       Date:  2018-01-03       Impact factor: 2.980

Review 4.  New Insights into Pericarditis: Mechanisms of Injury and Therapeutic Targets.

Authors:  Bo Xu; Serge C Harb; Paul C Cremer
Journal:  Curr Cardiol Rep       Date:  2017-07       Impact factor: 2.931

Review 5.  Echocardiography in the Assessment of Patients with Rheumatologic Diseases.

Authors:  Maha A Al-Mohaissen; Kwan-Leung Chan
Journal:  Curr Cardiol Rep       Date:  2016-08       Impact factor: 2.931

Review 6.  CXCL13 as a new biomarker of systemic lupus erythematosus and lupus nephritis - from bench to bedside?

Authors:  L Schiffer; K Worthmann; H Haller; M Schiffer
Journal:  Clin Exp Immunol       Date:  2015-01       Impact factor: 4.330

7.  Prevalence of resting-ECG abnormalities in systemic lupus erythematosus: a single-center experience.

Authors:  Gihyun Myung; Lindsy J Forbess; Mariko L Ishimori; Sumeet Chugh; Daniel Wallace; Michael H Weisman
Journal:  Clin Rheumatol       Date:  2017-02-25       Impact factor: 2.980

Review 8.  Protective and Pathogenic Effects of Interferon Signaling During Pregnancy.

Authors:  Rebecca L Casazza; Helen M Lazear; Jonathan J Miner
Journal:  Viral Immunol       Date:  2019-09-23       Impact factor: 2.257

9.  SLE or hypothyroidism: who can triumph in cardiac tamponade?

Authors:  Sameer Sadashiv Chaudhari; Kashmira Pramod Wankhedkar; Savi Mushiyev
Journal:  BMJ Case Rep       Date:  2015-03-06

10.  Acute Cardiac Tamponade in a 58-Year-Old Male with Poststreptococcal Glomerulonephritis.

Authors:  Wendy Bottinor; Daniel Fronk; Salima Sadruddin; Harriet Foster; Nilang Patel; Andreas Prinz; Ion S Jovin
Journal:  Methodist Debakey Cardiovasc J       Date:  2016-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.